These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 1286761

  • 1. The future European system for the free circulation of veterinary vaccines in Europe.
    Hankin R.
    Dev Biol Stand; 1992; 79():3-9. PubMed ID: 1286761
    [Abstract] [Full Text] [Related]

  • 2. [Europe and medicines: role of the EMEA].
    Sauer F.
    Ann Pharm Fr; 2000 Jul; 58(4):278-85. PubMed ID: 10915977
    [Abstract] [Full Text] [Related]

  • 3. European regulations relevant to the marketing and use of fish vaccines.
    Lee A.
    Dev Biol Stand; 1997 Jul; 90():341-6. PubMed ID: 9270862
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [European registration of veterinary drugs].
    Reijnders PJ.
    Tijdschr Diergeneeskd; 1993 Apr 15; 118(8):271-4. PubMed ID: 8484182
    [Abstract] [Full Text] [Related]

  • 6. Regulation of immunological veterinary medicinal products in the European Union.
    Brunko P.
    Rev Sci Tech; 1995 Dec 15; 14(4):1133-41. PubMed ID: 8639951
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Veterinary pharmacovigilance. Part 1. The legal basis in the European Union.
    Woodward KN.
    J Vet Pharmacol Ther; 2005 Apr 15; 28(2):131-47. PubMed ID: 15842304
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Marketing authorization of veterinary medicinal products in Poland.
    Sztabińska-Koncka H, Lewicki J.
    Regul Toxicol Pharmacol; 1997 Aug 15; 26(1 Pt 1):129-33. PubMed ID: 9339489
    [Abstract] [Full Text] [Related]

  • 13. Regulatory environment for allergen-specific immunotherapy.
    Kaul S, May S, Lüttkopf D, Vieths S.
    Allergy; 2011 Jun 15; 66(6):753-64. PubMed ID: 21288251
    [Abstract] [Full Text] [Related]

  • 14. Extraneous agents testing for substrates of avian origin and viral vaccines for poultry: current provisions and proposals for future approaches.
    Jungbäck C, Motitschke A.
    Biologicals; 2010 May 15; 38(3):362-5. PubMed ID: 20335053
    [Abstract] [Full Text] [Related]

  • 15. [Drugs in Europe].
    Bouzy C, Abadie E.
    Rev Prat; 2002 Mar 01; 52(5):510-4. PubMed ID: 11949504
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Community requirements relating to drugs derived from human blood and plasma].
    Brunko P.
    Ann Pharm Fr; 1994 Mar 01; 52(2):89-98. PubMed ID: 7944184
    [Abstract] [Full Text] [Related]

  • 18. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
    Coppens P, da Silva MF, Pettman S.
    Toxicology; 2006 Apr 03; 221(1):59-74. PubMed ID: 16469424
    [Abstract] [Full Text] [Related]

  • 19. [Legal requirements for health protection from the European viewpoint--uniform regulations or reciprocal recognition of public health norms?].
    Schlüter P.
    Zentralbl Hyg Umweltmed; 1996 Dec 03; 199(2-4):105-18. PubMed ID: 9409912
    [Abstract] [Full Text] [Related]

  • 20. The regulatory system in europe with special emphasis on allergen products.
    Lorenz AR, Luttkopf D, Seitz R, Vieths S.
    Int Arch Allergy Immunol; 2008 Dec 03; 147(4):263-75. PubMed ID: 18648190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.